Sign in

CIK 0000879169

  • Large accelerated filer

INCYTE CORP

Sign in to watch
Ticker
INCY
Exchange
Nasdaq
Industry
Services-Commercial Physical & Biological Research
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
943136539
Phone
+1 302-498-6700
Business address
1801 AUGUSTINE CUT-OFF, WILMINGTON, DE, 19803
Former names
INCYTE INC, INCYTE GENOMICS INC, INCYTE PHARMACEUTICALS INC
  1. 4 Grant or award Director acquired 3,284 shares (grant or award)
  2. 4 Grant or award Director acquired 1,642 shares (grant or award)
  3. 4 Grant or award Director acquired 1,642 shares (grant or award)
  4. 4 Grant or award Director acquired 1,642 shares (grant or award)
  5. 4 Grant or award Director acquired 1,642 shares (grant or award)
  6. 4 Grant or award Director acquired 1,642 shares (grant or award)
  7. 4 Grant or award Director acquired 1,642 shares (grant or award)
  8. 4 Planned sale Principal Accounting Officer sold 2,639 shares at $100.00 ($263,900)
  9. 4 Shares withheld for taxes President, Global Head of R&D gave up 25,469 shares (to pay taxes)
  10. 4 Planned sale Principal Accounting Officer sold 2,051 shares at $97.35 ($199,665)
  11. 4 Shares withheld for taxes Director gave up 13,059 shares (to pay taxes)
  12. 4 Planned sale Director sold 15,000 shares at $94.93 ($1,423,950)
  13. 4/A Grant or award CMO & Head of Late-Stage Dev. acquired 44,124 shares (grant or award)
  14. 4/A Grant or award President, Global Head of R&D acquired 31,517 shares (grant or award)
  15. 4 Exercise or conversion Director acquired 30,000 shares (option exercise)
  16. 4 Grant or award EVP & Chief Financial Officer acquired 26,343 shares (grant or award)
  17. 3 Insider Initial Statement of Ownership
  18. 4 Planned sale President, Global Head of R&D sold 18,667 shares at $96.50 ($1,801,366)
  19. 4 Exercise or conversion Chief Executive Officer acquired 125,000 shares (option exercise)
  20. 4 Grant or award President, Global Head of R&D acquired 27,892 shares (grant or award)

Page 3 of 82 · 1,626 filings